businesspress24.com - Notice of Paladin Labs' First Quarter 2011 Results Conference Call
 

Notice of Paladin Labs' First Quarter 2011 Results Conference Call

ID: 1027565

(firmenpresse) - MONTREAL, CANADA -- (Marketwire) -- 08/04/11 -- Paladin Labs Inc. (TSX: PLB), a leading Canadian specialty pharmaceutical company, will release its second quarter 2011 financial results on Thursday, August 11, 2011 prior to market opening. Following the release, Paladin will hold a conference call at 10:00 a.m. (EST) hosted by Jonathan Ross Goodman, President and CEO of Paladin Labs. Paladin cordially invites all interested parties to participate in this call.

CONFERENCE CALL DETAILS:

The call will also be audio-cast live and archived for 30 days at .

About Paladin Labs Inc.

Paladin Labs Inc., headquartered in Montreal, Canada, is a specialty pharmaceutical company focused on acquiring or in-licensing innovative pharmaceutical products for the Canadian and world markets. With this strategy, a focused national sales team and proven marketing expertise, Paladin has evolved into one of Canada's leading specialty pharmaceutical companies. Paladin's shares trade on the Toronto Stock Exchange under the symbol PLB. For more information about Paladin, please visit the Company's web site at .

This press release may contain forward-looking statements and predictions. These forward-looking statements, by their nature, necessarily involve risks and uncertainties that could cause actual results to differ materially from those contemplated by the forward-looking statements. The Company considers the assumptions on which these forward-looking statements are based to be reasonable at the time they were prepared, but cautions that these assumptions regarding the future events, many of which are beyond the control of the Company and its subsidiaries, may ultimately prove to be incorrect. Factors and risks, which could cause actual results to differ materially from current expectations, are discussed in the annual report as well as in the Company's Annual Information Form for the year ended December 31, 2010. The Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information or future events and except as required by law. For additional information on risks and uncertainties relating to these forward-looking statements, investors should consult the Company's ongoing quarterly fillings, annual report and Annual Information Form and other fillings found on SEDAR at .







Contacts:
Samira Sakhia, CA, MBA
Chief Financial Officer
Paladin Labs Inc.
514-669-5367
514-344-4675 (FAX)


Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  PharmaGap Completes $496,405 Private Placement
Allon Granted U.S. Patent for Davunetide as a Treatment for Schizophrenia
Bereitgestellt von Benutzer: MARKET WIRE
Datum: 04.08.2011 - 06:30 Uhr
Sprache: Deutsch
News-ID 1027565
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

MONTREAL, CANADA


Phone:

Kategorie:

Biotech


Anmerkungen:


Diese Pressemitteilung wurde bisher 116 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Notice of Paladin Labs' First Quarter 2011 Results Conference Call
"
steht unter der journalistisch-redaktionellen Verantwortung von

Paladin Labs Inc. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Paladin Labs Inc.



 

Who is online

All members: 10 563
Register today: 0
Register yesterday: 2
Members online: 0
Guests online: 71


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.